CH622672A5 - - Google Patents
Download PDFInfo
- Publication number
- CH622672A5 CH622672A5 CH1288976A CH1288976A CH622672A5 CH 622672 A5 CH622672 A5 CH 622672A5 CH 1288976 A CH1288976 A CH 1288976A CH 1288976 A CH1288976 A CH 1288976A CH 622672 A5 CH622672 A5 CH 622672A5
- Authority
- CH
- Switzerland
- Prior art keywords
- platelets
- platelet
- tanning agent
- treatment
- carries out
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 239000000427 antigen Substances 0.000 claims description 10
- 102000036639 antigens Human genes 0.000 claims description 10
- 108091007433 antigens Proteins 0.000 claims description 10
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 8
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 239000002738 chelating agent Substances 0.000 claims description 6
- 239000000084 colloidal system Substances 0.000 claims description 6
- 230000001681 protective effect Effects 0.000 claims description 6
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 239000008291 lyophilic colloid Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 1
- 210000001772 blood platelet Anatomy 0.000 description 46
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000013049 sediment Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229920001864 tannin Polymers 0.000 description 4
- 239000001648 tannin Substances 0.000 description 4
- 235000018553 tannin Nutrition 0.000 description 4
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- YCPXWRQRBFJBPZ-UHFFFAOYSA-N 5-sulfosalicylic acid Chemical compound OC(=O)C1=CC(S(O)(=O)=O)=CC=C1O YCPXWRQRBFJBPZ-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 210000004623 platelet-rich plasma Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229910021556 Chromium(III) chloride Inorganic materials 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 150000001844 chromium Chemical class 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- 239000011636 chromium(III) chloride Substances 0.000 description 1
- 235000007831 chromium(III) chloride Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 230000000093 cytochemical effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229950009241 sodium timerfonate Drugs 0.000 description 1
- LUKFIMQJXRYJNK-UHFFFAOYSA-L sodium;ethyl-(4-sulfonatophenyl)sulfanylmercury Chemical compound [Na+].CC[Hg]SC1=CC=C(S([O-])(=O)=O)C=C1 LUKFIMQJXRYJNK-UHFFFAOYSA-L 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/80—Fluorescent dyes, e.g. rhodamine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752546166 DE2546166A1 (de) | 1975-10-15 | 1975-10-15 | Gegerbte thrombozyten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH622672A5 true CH622672A5 (cg-RX-API-DMAC10.html) | 1981-04-30 |
Family
ID=5959204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1288976A CH622672A5 (cg-RX-API-DMAC10.html) | 1975-10-15 | 1976-10-12 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4157383A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS5247916A (cg-RX-API-DMAC10.html) |
| AT (1) | AT355228B (cg-RX-API-DMAC10.html) |
| AU (1) | AU511176B2 (cg-RX-API-DMAC10.html) |
| BE (1) | BE847354A (cg-RX-API-DMAC10.html) |
| CA (1) | CA1077394A (cg-RX-API-DMAC10.html) |
| CH (1) | CH622672A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE2546166A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK463776A (cg-RX-API-DMAC10.html) |
| FR (1) | FR2328189A1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1554886A (cg-RX-API-DMAC10.html) |
| IT (1) | IT1069039B (cg-RX-API-DMAC10.html) |
| LU (1) | LU75987A1 (cg-RX-API-DMAC10.html) |
| NL (1) | NL7611152A (cg-RX-API-DMAC10.html) |
| SE (1) | SE7611505L (cg-RX-API-DMAC10.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989006976A1 (en) * | 1988-02-01 | 1989-08-10 | Quadrant Bioresources Limited | Method of drying macromolecules |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4287087A (en) * | 1977-02-25 | 1981-09-01 | Research Triangle Institute | Fixed-dried blood platelets |
| US4302355A (en) * | 1977-08-01 | 1981-11-24 | Warner-Lambert Company | Platelet reference control |
| JPS5465095A (en) * | 1977-11-02 | 1979-05-25 | Toa Medical Electronics | Diluted liquid for counting blood platelets |
| JPS54107396A (en) * | 1978-02-09 | 1979-08-23 | Toa Medical Electronics | Blood checking device |
| US4219440A (en) * | 1979-06-06 | 1980-08-26 | Coulter Electronics, Inc. | Multiple analysis hematology reference control reagent and method of making the same |
| DE2847877A1 (de) * | 1978-11-04 | 1980-05-22 | Behringwerke Ag | Reagenz zum nachweis der infektioesen mononucleose |
| US4264470A (en) * | 1979-05-07 | 1981-04-28 | Coulter Electronics, Inc. | Selecting goat erythrocytes to simulate human platelets in hematologic reference controls |
| US4324686A (en) * | 1979-06-11 | 1982-04-13 | R & D Systems, Inc. | Hematology control composition and methods for its use |
| US4310508A (en) * | 1979-06-19 | 1982-01-12 | Siber George | Diagnostic test and reagent therefor |
| DE2949824A1 (de) * | 1979-12-12 | 1981-07-02 | Marianne Dr. 5000 Köln Sehrbundt | Verfahren zur stabilisierung von lymphozyten/thrombozytennmischsuspensionen |
| DE3009126A1 (de) * | 1980-03-10 | 1981-10-08 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Verfahren zur gewinnung von funktionell und morphologisch intakten und lebensfaehigen leukozyten aus blut |
| US4405719A (en) * | 1981-05-29 | 1983-09-20 | Coulter Electronics, Inc. | Method of stabilizing platelets for determining multiple platelet parameters in reference control and calibrator compositions; diluents therefor; and combination stabilization procedures |
| DE3141894A1 (de) * | 1981-10-22 | 1983-05-05 | Behringwerke Ag, 3550 Marburg | Reagenz fuer die bestimmung des ristocetin-cofaktors (v. willebrand-faktor) |
| US4471051A (en) * | 1983-06-13 | 1984-09-11 | New England Medical Center Hospitals, Inc. | Stabilization of neutrophils and platelets |
| US4717654A (en) * | 1984-06-19 | 1988-01-05 | Akzo N.V. | Process for solid phase platelet antibody assay |
| EP0186476A3 (en) * | 1984-12-21 | 1987-10-21 | Hemochek Corporation | Diagnostic kit and method for assaying blood components |
| US4731330A (en) * | 1986-07-01 | 1988-03-15 | Biotrack, Inc. | Whole blood control sample |
| US5213814A (en) * | 1989-04-10 | 1993-05-25 | Cryopharm Corporation | Lyophilized and reconstituted blood platelet compositions |
| DE69333924T2 (de) * | 1992-05-29 | 2006-08-17 | University Of North Carolina At Chapel Hill | Im immobilisierten Zustand getrocknete pharmazeutisch verträgliche menschliche Blutplättchen |
| WO2004057036A1 (en) * | 2002-12-23 | 2004-07-08 | Council Of Scientific And Industrial Research | Process for preparing a synthetic aluminium tanning agent |
| US7169191B2 (en) | 2003-03-20 | 2007-01-30 | Council Of Scientific And Industrial Research | Process for preparing a synthetic aluminium tanning agent |
| EP3694322B1 (en) | 2017-10-09 | 2024-07-03 | Terumo BCT Biotechnologies, LLC | Lyophilization container and method of using same |
| US20200224164A1 (en) | 2018-11-30 | 2020-07-16 | Cellphire, Inc. | Platelets as delivery agents |
| EP3886879A4 (en) | 2018-11-30 | 2022-12-07 | Cellphire Inc. | PLATES AS DELIVERY AGENTS |
| JP7541993B2 (ja) | 2019-03-14 | 2024-08-29 | テルモ ビーシーティー バイオテクノロジーズ，エルエルシー | 凍結乾燥用ローディングトレイ組立体、凍結乾燥システム及び凍結乾燥方法 |
| CN114072159A (zh) | 2019-05-03 | 2022-02-18 | 塞尔菲乐有限公司 | 用于生产血液产品的材料和方法 |
| US11701388B2 (en) | 2019-08-16 | 2023-07-18 | Cellphire, Inc. | Thrombosomes as an antiplatelet agent reversal agent |
| US20210308185A1 (en) | 2020-02-04 | 2021-10-07 | Cellphire, Inc. | Methods of treating acquired hemophilia with anti-fibrinolytic loaded platelets |
| TW202245814A (zh) | 2021-02-17 | 2022-12-01 | 美商賽菲爾公司 | 用於治療抗血小板誘導的凝血病之凍乾血小板衍生物組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6509726A (cg-RX-API-DMAC10.html) * | 1965-07-28 | 1967-01-30 | ||
| US3426123A (en) * | 1965-09-10 | 1969-02-04 | Princeton Lab Inc | Diagnostic test for infectious mononucleosis with aldehyde treated equine erythrocytes |
| US3553310A (en) * | 1967-12-28 | 1971-01-05 | Miles Lab | Immunologically reactive particles |
| US3753357A (en) * | 1970-12-14 | 1973-08-21 | Ovitron Res Corp | Method and apparatus for the preservation of cells and tissues |
| IT1055851B (it) * | 1974-08-30 | 1982-01-11 | Behringwerke Ag | Particelle indicatirci per diagnosi in vitro |
-
1975
- 1975-10-15 DE DE19752546166 patent/DE2546166A1/de not_active Withdrawn
-
1976
- 1976-10-08 NL NL7611152A patent/NL7611152A/xx not_active Application Discontinuation
- 1976-10-12 CH CH1288976A patent/CH622672A5/de not_active IP Right Cessation
- 1976-10-13 IT IT7628275A patent/IT1069039B/it active
- 1976-10-13 LU LU75987A patent/LU75987A1/xx unknown
- 1976-10-13 US US05/732,134 patent/US4157383A/en not_active Expired - Lifetime
- 1976-10-14 DK DK463776A patent/DK463776A/da unknown
- 1976-10-14 AT AT765676A patent/AT355228B/de not_active IP Right Cessation
- 1976-10-14 CA CA263,346A patent/CA1077394A/en not_active Expired
- 1976-10-14 AU AU18694/76A patent/AU511176B2/en not_active Expired
- 1976-10-14 GB GB42757/76A patent/GB1554886A/en not_active Expired
- 1976-10-15 JP JP51124380A patent/JPS5247916A/ja active Pending
- 1976-10-15 FR FR7631043A patent/FR2328189A1/fr active Granted
- 1976-10-15 SE SE7611505A patent/SE7611505L/xx unknown
- 1976-10-15 BE BE171564A patent/BE847354A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989006976A1 (en) * | 1988-02-01 | 1989-08-10 | Quadrant Bioresources Limited | Method of drying macromolecules |
Also Published As
| Publication number | Publication date |
|---|---|
| DK463776A (da) | 1977-04-16 |
| JPS5247916A (en) | 1977-04-16 |
| FR2328189A1 (fr) | 1977-05-13 |
| CA1077394A (en) | 1980-05-13 |
| NL7611152A (nl) | 1977-04-19 |
| AT355228B (de) | 1980-02-25 |
| AU511176B2 (en) | 1980-07-31 |
| SE7611505L (sv) | 1977-04-16 |
| GB1554886A (en) | 1979-10-31 |
| LU75987A1 (cg-RX-API-DMAC10.html) | 1977-05-25 |
| IT1069039B (it) | 1985-03-21 |
| BE847354A (fr) | 1977-04-15 |
| AU1869476A (en) | 1978-04-20 |
| FR2328189B1 (cg-RX-API-DMAC10.html) | 1982-03-12 |
| ATA765676A (de) | 1979-07-15 |
| US4157383A (en) | 1979-06-05 |
| DE2546166A1 (de) | 1977-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH622672A5 (cg-RX-API-DMAC10.html) | ||
| DE2551208C3 (de) | Verfahren zur Herstellung einer stabilen Erythrozyten-Präparation | |
| CH646607A5 (de) | Haemostatisches mittel und verfahren zu seiner herstellung. | |
| DE2322562C2 (de) | Verfahren zur Bestimmung von Antigenen in einer Probe | |
| DE2628468C2 (de) | Verfahren zur Färbung von Basophilen und Reagens zur Durchführung dieses Verfahrens | |
| DE2163318C3 (de) | Verfahren zur Herstellung von zur passiven Agglutination geeigneten Tra gerteilchen aus mit Formaldehyd be handelten Mikroorganismen | |
| WO2019025387A1 (de) | Verfahren und zusammensetzung zur stabilisierung zellfreier nukleinsäuren und zellen | |
| DE2850950C3 (de) | Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren | |
| DE2712044A1 (de) | Stabile immunologische reagenzien | |
| CH646259A5 (de) | Diagnostisches mittel zur bestimmung eines antigens. | |
| DE2025718B2 (de) | Verfahren zum Stabilisieren von lyophilisierten Erythrozyten | |
| EP0011716B1 (de) | Reagenz zum Nachweis von infektiöser Mononucleose und Verfahren zu seiner Herstellung | |
| DE1920866A1 (de) | Reagens fuer einen diagnostischen Test auf Mononucleosis infectiosa und Verfahren zu seiner Herstellung | |
| DE2235600B2 (de) | Verfahren zur Reinigung von T -Globulin | |
| DE2243237A1 (de) | Nachweis der immunreaktion gegenueber krebs | |
| AT215599B (de) | Verfahren zur Herstellung eines Plasmapräparates zur Frühdiagnose des Karzinoms | |
| CH526631A (de) | Mittel zur Herstellung eines immunologischen Indikators, Verfahren zu dessen Herstellung und dessen Verwendung | |
| DE2356493C3 (de) | Verfahren zur Herstellung eines Thromboplastins und diagnostisches Mittel zur Kontrolle der Gerinnungsfähigkeit des Blutes | |
| DE854009C (de) | Verfahren zur Gewinnung von Blutplasma | |
| AT106981B (de) | Verfahren zur Herstellung von säurefreien, reinen, harzartigen Kondensationsprodukten aus Phenolen und Aldehyden. | |
| DE874061C (de) | Verfahren zur Herstellung einer blutgerinnungsfoerdernden Substanz aus Lunge | |
| AT258466B (de) | Verfahren und Reagenz zur Bestimmung von menschlichem chorionischem Gonadotrophin | |
| DE2606257A1 (de) | Recognine | |
| DE1808435C3 (de) | Verfahren zum Stabilisieren von Erythrozyten | |
| CH528083A (de) | Immunologischer Indikator, Verfahren zu dessen Herstellung und dessen Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |